Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 31, 2022SHILAP Revista de lepidopterologíaOpen Access

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

KPKevin PanVanderbilt UniversityHFHizra FarrukhHarvard UniversityVCVeera Chandra Sekhar Reddy ChittepuBrigham and Women's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pan et al. (2022) studied this question.

synapsesocial.com/papers/69dff6a4bdd89ea53186078bhttps://doi.org/10.1186/s13046-022-02327-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Novel strategies for immuno-oncology breakthroughs with cell therapy2021 · 21 citations
  2. 2CAR T cells: Building on the CD19 paradigm2021 · 69 citations
  3. 3Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity2015 · 405 citations
  4. 4M-1/M-2 Macrophages and the Th1/Th2 Paradigm2000 · 3,352 citations
  5. 5HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis2006 · 5,458 citations